# Should cannabis law be reformed in England and Wales
## Introduction
The legal status of cannabis in England and Wales has been a subject of continuous debate. Under the Misuse of Drugs Act 1971, cannabis is classified as a Class B drug, making its possession, supply, and production criminal offences. However, evolving social attitudes, experiences from other jurisdictions that have legalised or decriminalised cannabis, and a growing recognition of its potential medicinal uses have intensified calls for reform. This essay will explore the main arguments for and against reforming cannabis law. It will argue that while the case for reform presents some compelling economic and social justice points, the significant public health risks associated with legalisation mean that the current prohibitive stance, tempered by exceptions for medical use, remains the most prudent approach for England and Wales at this time.
## The Current Legal Framework
The primary legislation governing cannabis is the Misuse of Drugs Act 1971. As a Class B drug, possession of cannabis carries a maximum sentence of five years’ imprisonment, an unlimited fine, or both. The supply or production of cannabis carries a much stricter maximum sentence of 14 years’ imprisonment (Misuse of Drugs Act 1971, Sch 4). In practice, police often use their discretion for simple possession cases, issuing warnings or on-the-spot fines rather than pursuing prosecution, particularly for first-time offenders.
A significant, albeit limited, reform occurred in 2018 when the law was changed to allow specialist doctors to prescribe cannabis-based products for medicinal use. This was prompted by high-profile cases of children with severe epilepsy who benefited from cannabis oil. However, access remains tightly restricted and is limited to patients for whom other licensed medicines have failed, meaning it is not widely available on the NHS (NHS, 2021). This partial reform shows a willingness from the government to acknowledge the drug’s therapeutic potential, but it stops far short of the wider legalisation sought by campaigners.
## Arguments for Reform
There are several key arguments in favour of a more fundamental reform of cannabis laws, moving towards either decriminalisation or a fully regulated legal market. A primary argument is economic. Jurisdictions such as Canada and several US states have demonstrated that a legal cannabis market can generate significant tax revenue, which could be used to fund public services like healthcare and education. This would also create new jobs in cultivation, distribution, and retail (Kilmer, 2010).
Furthermore, proponents of reform argue that prohibition has failed to curb use but has succeeded in criminalising large numbers of people, disproportionately affecting young and ethnic minority individuals. A report on drug misuse statistics showed that cannabis was the most commonly used drug in the last year (Home Office, 2020). Ending prohibition could free up police time and court resources to focus on more serious crimes, and it would prevent individuals from gaining a criminal record for an offence that many consider to be relatively minor (Stevens, 2011). Finally, a regulated market would improve public safety. Illegal cannabis can be of unknown strength or contaminated with other substances. A legal framework would allow for government control over the potency (THC levels), purity, and packaging of cannabis products, providing consumers with more safety and information.
## Arguments Against Reform
Despite the points in favour of reform, there are significant arguments for maintaining the current legal status of cannabis. The most prominent of these are the concerns surrounding public health. There is a substantial body of medical evidence linking heavy cannabis use, particularly high-potency strains, with an increased risk of developing serious mental health problems, including psychosis and schizophrenia (Di Forti et al., 2015). The risk is considered to be especially high for adolescents, whose brains are still developing. Opponents of legalisation worry that it would normalise cannabis use, leading to increased rates of consumption and, consequently, a greater burden on mental health services.
Another argument is the fear that legalisation could lead to higher rates of addiction and could act as a ‘gateway’ to the use of harder drugs, although the evidence for this ‘gateway theory’ is contested (Stevens, 2011). There are also practical challenges associated with legalisation, such as establishing effective regulations for driving under the influence of cannabis and preventing underage access. Finally, the UK is a signatory to international treaties, such as the 1961 UN Single Convention on Narcotic Drugs, which commit it to prohibiting the production and supply of drugs like cannabis for non-medical purposes. While not an insurmountable barrier, radical legalisation would place the UK in conflict with these long-standing international obligations.
## Conclusion
In conclusion, the debate over cannabis law reform involves a difficult balancing act between personal freedom, economic opportunity, and public health. The arguments for legalisation—based on potential tax revenue, reducing the burden on the criminal justice system, and improving product safety—are significant and have proven persuasive in other countries. However, they are not strong enough to outweigh the serious and well-documented public health risks, particularly concerning the mental health of young people. The potential for increased addiction and the practical difficulties of implementing a safe regulatory framework present further obstacles. Therefore, while the current law is not perfect, its cautious approach of general prohibition combined with a narrow, medically-supervised exception is a reasonable compromise. Further liberalisation may be possible in the future, but it should only be considered if stronger evidence emerges that the associated health risks can be effectively managed.
## References
- Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Bonomo, M., G. P. et al. (2015) The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet Psychiatry, 2(3), pp.233-241.
- Home Office. (2020) Drug misuse: findings from the 2019 to 2020 Crime Survey for England and Wales. London: Home Office.
- Kilmer, B. (2010) ‘Market size and demand for marijuana’ in Kilmer, B., Caulkins, J. P., Pacula, R. L., & Reuter, P. (eds.) Altered State?: Assessing How Marijuana Legalization in California Could Influence Marijuana Consumption and Public Budgets. RAND Corporation.
- Misuse of Drugs Act 1971.
- NHS. (2021) Medical cannabis (and cannabis oils). Available at: https://www.nhs.uk/conditions/medical-cannabis/ (Accessed: 15 October 2023).
- Stevens, A. (2011) Drugs, Crime and Public Health: The Political Economy of Drug Policy. London: Routledge.
